Interventional cardiologists are able to perform minimally invasive procedures, such as angioplasty and stenting, due to imaging technologies that allow them to see inside the heart and blood vessels without open surgery. Such imaging often requires injection of contrast media, which are generally safe, but for some patients with drug sensitivities or compromised kidney function, contrast-induced nephropathy (CIN) can result. CIN is a major complication that can increase in-hospital mortality. This issue of Interventional Cardiology Clinica addresses the management, treatment, and prevention of renal complications in the catheterization laboratory.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Contents - p. 5 6. Forthcoming Issues - p. 7 7. Preface - p. 8 8. Implications of Kidney Disease in the Cardiac Patient - p. 9 9. Contrast Media - p. 21 10. Nonrenal Complications of Contrast Media - p. 26 11. Relative Nephrotoxicity of Different Contrast Media - p. 32 12. Contrast-Induced Nephropathy - p. 38 13. Pathophysiology of Contrast-Induced Acute Kidney Injury - p. 42 14. Predicting Contrast-induced Renal Complications in the Catheterization Laboratory - p. 46 15. Biomarkers of Contrast-Induced Nephropathy - p. 52 16. Intravenous and Oral Hydration - p. 60 17. Pharmacologic Prophylaxis for Contrast-Induced Acute Kidney Injury - p. 68 18. Device-Based Therapy in the Prevention of Contrast-Induced Nephropathy - p. 76 19. A Practical Approach to Preventing Renal Complications in the Catheterization Laboratory - p. 83 20. Renal Complications in Patients Undergoing Peripheral Artery Interventions - p. 92 21. Renal Complications in Patients Undergoing Transcatheter Aortic Valve Replacement - p. 99 22. Index - p. 104
No hay muestra disponible
No hay ficha técnica disponible
Interventional cardiologists are able to perform minimally invasive procedures, such as angioplasty and stenting, due to imaging technologies that allow them to see inside the heart and blood vessels without open surgery. Such imaging often requires injection of contrast media, which are generally safe, but for some patients with drug sensitivities or compromised kidney function, contrast-induced nephropathy (CIN) can result. CIN is a major complication that can increase in-hospital mortality. This issue of Interventional Cardiology Clinica addresses the management, treatment, and prevention of renal complications in the catheterization laboratory.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Contents - p. 5 6. Forthcoming Issues - p. 7 7. Preface - p. 8 8. Implications of Kidney Disease in the Cardiac Patient - p. 9 9. Contrast Media - p. 21 10. Nonrenal Complications of Contrast Media - p. 26 11. Relative Nephrotoxicity of Different Contrast Media - p. 32 12. Contrast-Induced Nephropathy - p. 38 13. Pathophysiology of Contrast-Induced Acute Kidney Injury - p. 42 14. Predicting Contrast-induced Renal Complications in the Catheterization Laboratory - p. 46 15. Biomarkers of Contrast-Induced Nephropathy - p. 52 16. Intravenous and Oral Hydration - p. 60 17. Pharmacologic Prophylaxis for Contrast-Induced Acute Kidney Injury - p. 68 18. Device-Based Therapy in the Prevention of Contrast-Induced Nephropathy - p. 76 19. A Practical Approach to Preventing Renal Complications in the Catheterization Laboratory - p. 83 20. Renal Complications in Patients Undergoing Peripheral Artery Interventions - p. 92 21. Renal Complications in Patients Undergoing Transcatheter Aortic Valve Replacement - p. 99 22. Index - p. 104
No hay muestra disponible
No hay ficha técnica disponible
